Published in Hematol Oncol Clin North Am on June 01, 2009
A case of S-100 negative melanoma: A diagnostic pitfall in the workup of a poorly differentiated metastatic tumor of unknown origin. Cytojournal (2016) 0.75
Visualization of melanoma tumor with lectin-conjugated rare-earth doped fluoride nanocrystals. Croat Med J (2014) 0.75
Study of 448 cases of melanoma in situ in two hospitals in Rio de Janeiro. An Bras Dermatol (2017) 0.75
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Melanoma. N Engl J Med (2006) 8.80
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A (2003) 5.49
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A (2008) 4.43
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell (2012) 4.04
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol (2003) 2.81
De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype -- a clinical and pathological study of 75 patients. J Cutan Pathol (2005) 2.38
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature (2012) 2.35
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol (2004) 2.29
Pyoderma gangrenosum: a review. J Cutan Pathol (2003) 2.23
Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol (2005) 2.22
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol (2005) 2.12
Unusual variants of malignant melanoma. Mod Pathol (2006) 1.93
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun (2009) 1.74
Cutaneous vasculitis: a review. J Cutan Pathol (2003) 1.74
Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol (2005) 1.71
State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol (2010) 1.68
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
Pigmented epithelioid melanocytoma: report of first Japanese cases previously diagnosed as cellular blue nevus. J Cutan Pathol (2009) 1.48
Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res (2010) 1.47
Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model. J Invest Dermatol (2003) 1.42
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. Proc Natl Acad Sci U S A (2009) 1.34
Current concepts of metastasis in melanoma. Expert Rev Dermatol (2008) 1.34
PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma. J Am Acad Dermatol (2003) 1.33
Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res (2008) 1.29
The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol (2008) 1.28
Malignant adnexal neoplasms. Mod Pathol (2006) 1.26
Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med (2010) 1.21
SOX2 contributes to melanoma cell invasion. Lab Invest (2011) 1.21
Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer (2007) 1.18
Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model. J Hematol Oncol (2011) 1.18
Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol (2005) 1.17
Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol (2014) 1.12
Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. Am J Surg Pathol (2011) 1.11
Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol (2004) 1.10
Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch Dermatol (2008) 1.10
Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol (2006) 1.09
Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. J Am Acad Dermatol (2002) 1.08
Drug-induced linear IgA bullous dermatosis. J Dermatol (2005) 1.07
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol (2011) 1.06
Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol (2009) 1.06
De novo intraepidermal epithelioid melanocytic dysplasia: an emerging entity. J Cutan Pathol (2009) 1.06
Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol (2010) 1.04
The nonrandom distribution of facial hemangiomas. Arch Dermatol (2003) 1.03
Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol (2009) 1.03
AJCC melanoma staging update: impact on dermatopathology practice and patient management. J Cutan Pathol (2011) 1.02
Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol (2009) 1.02
Markers and tissue resources for melanoma: meeting report. Cancer Res (2006) 1.01
Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One (2012) 1.01
Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol (2008) 1.01
Molecular mechanisms of metastasis. Cancer Metastasis Rev (2006) 1.00
Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration. Technology (Singap World Sci) (2013) 0.99
Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol (2014) 0.99
Immunoglobulin-A--associated small-vessel vasculitis: a 10-year experience at the Massachusetts General Hospital. J Am Acad Dermatol (2011) 0.99
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med (2004) 0.96
Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol (2007) 0.96
Bullous reactions to bedbug bites reflect cutaneous vasculitis. Am J Med (2012) 0.96
Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol (2006) 0.95
Interface dermatitis. Arch Pathol Lab Med (2008) 0.95
Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol (2002) 0.94
Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers Surg Med (2012) 0.93
Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas. Am J Surg Pathol (2005) 0.93
Increased diagnosis of thin superficial spreading melanomas: A 20-year study. J Am Acad Dermatol (2011) 0.93
Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration. Lasers Surg Med (2011) 0.92
Current knowledge of the pathogenesis of infantile hemangiomas. Arch Facial Plast Surg (2005) 0.92
Reflectance confocal microscopy may differentiate acute allergic and irritant contact dermatitis in vivo. J Am Acad Dermatol (2004) 0.92
Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol (2002) 0.92
The dermal-based borderline melanocytic tumor: a categorical approach. J Am Acad Dermatol (2010) 0.91
Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg (2004) 0.91
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol (2014) 0.91
Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Mod Pathol (2004) 0.91
Immunologic escape and angiogenesis in human malignant melanoma. J Am Acad Dermatol (2003) 0.90
Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol (2013) 0.90
Apocrine cystadenoma and apocrine hidrocystoma: examination of 21 cases with emphasis on nomenclature according to proliferative features. J Cutan Pathol (2007) 0.89
Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging. Am J Clin Pathol (2003) 0.88
Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials. Am J Clin Pathol (2010) 0.88
Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks. J Cutan Pathol (2010) 0.88
Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases. Am J Surg Pathol (2007) 0.88
Facial nerve hemangiomas: vascular tumors or malformations? Otolaryngol Head Neck Surg (2010) 0.88
Progression of cutaneous melanoma: implications for treatment. Clin Exp Metastasis (2012) 0.87
Unusual histologic and clinical variants of melanoma: implications for therapy. Curr Oncol Rep (2007) 0.87
Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Lasers Surg Med (2008) 0.87
In vivo examination of lentigo maligna and malignant melanoma in situ, lentigo maligna type by near-infrared reflectance confocal microscopy: comparison of in vivo confocal images with histologic sections. J Am Acad Dermatol (2002) 0.86
Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. Methods Mol Biol (2014) 0.86
Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol (2008) 0.85
Extensive neurocristic hamartoma with skeletal muscle involvement. J Cutan Pathol (2007) 0.85
Treatment of synchronous mucinous carcinoma and endocrine mucin-producing sweat gland carcinoma with Mohs' micrographic surgery. Dermatol Surg (2005) 0.85
An automated image processing method to quantify collagen fibre organization within cutaneous scar tissue. Exp Dermatol (2014) 0.84
Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: Morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol (2004) 0.84
A nonepidermal, primary malignant melanoma arising in a giant congenital melanocytic nevus 40 years after partial surgical removal. J Am Acad Dermatol (2004) 0.84
The molecular basis of melanomagenesis and the metastatic phenotype. Semin Oncol (2007) 0.84
Biomarkers in melanoma: stage III and IV disease. Expert Rev Mol Diagn (2005) 0.83
Tracking of second primary melanomas in vemurafenib-treated patients. JAMA Dermatol (2013) 0.83
Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol (2012) 0.83
Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic. J Am Acad Dermatol (2012) 0.83